Unaudited Financial Results (Standalone) for the Quarter and Nine Months ended 31.12.2024

OUTCOME OF THE MEETING OF THE BOARD OF DIRECTORS OF WELCURE DRUGS AND PHARMACEUTICALS LIMITED HELD ON TODAY 14 FEBRUARY 2025.

As per Attachment

This is to inform you that the Board of Directors of the Company at their meeting held on Friday, February 14, 2025, which commenced at 4:00 PM and concluded at 4.15 PM, has inter-alia considered and approved The Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended December 31, 2024, and Limited Review Report thereon.

Results for the quarter ended 31.12.2024

Enclosed herewith the Outcome of Board meeting along with Unaudited financial results for Quarter and 9 months ended 31st December 2024 followed by the Limited review Report

Declaration of Unaudited financial results for quarter and nine months ended on December 31, 2024.

As per Attachment.

Unaudited Financial Results for the quarter and nine month ended 31.12.2024

Unaudited Financial Results with Limited Audit Review Report for the 3rd quarter ended December 31, 2024, are attached. These results were approved by the Audit Committee and Board of Directors in their respective meetings on February 14, 2025.